Troxyca ER FDA Approval History
FDA Approved: Yes (Discontinued) (First approved August 19, 2016)
Brand name: Troxyca ER
Generic name: naltrexone and oxycodone
Dosage form: Extended-Release Capsules
Company: Pfizer Inc.
Treatment for: Pain
Marketing Status: Discontinued
Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent, narcotic analgesic formulation for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment.
Development timeline for Troxyca ER
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.